{
  "id": "matrixMatch_insulin_management_v2026_1771707348676_36",
  "type": "matrixMatch",
  "matrixType": "multipleChoice",
  "stem": "The nurse is caring for a client with a history of type 1 diabetes mellitus who was admitted for diabetic ketoacidosis (DKA). Based on the provided information, match each insulin type to its expected onset of action.",
  "itemContext": {
    "tabs": [
      {
        "id": "sbar",
        "title": "Nurses' Notes",
        "content": "10/26/2026 07:00\nS: Client reports feeling increasingly thirsty and nauseous since yesterday. States, \"I think I missed a dose of my insulin.\"\nB: 45-year-old male with a history of type 1 diabetes mellitus, admitted for DKA. Diagnosed 20 years ago. Recent HbA1c was 9.5%. Currently on insulin aspart (Novolog) 5 units before meals and insulin glargine (Lantus) 20 units at bedtime. \nA: Patient is alert and oriented x3, but exhibiting signs of dehydration. Blood glucose is currently 380 mg/dL. Has received 2L of NS bolus. Potassium is 3.1 mEq/L and has potassium replacement ordered. Continuous insulin infusion started at 2 units/hr per protocol.\nR: Continue monitoring blood glucose levels every hour. Administer insulin infusion per protocol, titrating to blood glucose levels. Monitor potassium levels and administer potassium replacement as prescribed. Educate patient on importance of adherence to insulin regimen and sick day management. Call provider for blood glucose >300 after 2 hours or any concerns. 07:15 - Notified Dr. Smith of lab values and current status."
      },
      {
        "id": "vitals",
        "title": "Vital Signs",
        "content": "10/26/2026 06:00\nBP: 110/70 mmHg\nHR: 110 bpm\nRR: 24 breaths/min, deep, Kussmaul respirations\nTemp: 38.2째C (100.8째F) Oral\nSpO2: 96% on room air\nBG: 380 mg/dL\n\n10/26/2026 07:00\nBP: 115/75 mmHg\nHR: 105 bpm\nRR: 22 breaths/min, deep\nTemp: 37.9째C (100.2째F) Oral\nSpO2: 97% on room air\nBG: 350 mg/dL"
      },
      {
        "id": "labs",
        "title": "Lab Results",
        "content": "10/26/2026 06:00\nGlucose: 380 mg/dL (70-110 mg/dL)\nPotassium: 3.1 mEq/L (3.5-5.0 mEq/L)\nSodium: 138 mEq/L (135-145 mEq/L)\nChloride: 100 mEq/L (95-105 mEq/L)\nBicarbonate: 15 mEq/L (22-29 mEq/L)\nBUN: 30 mg/dL (10-20 mg/dL)\nCreatinine: 1.5 mg/dL (0.6-1.2 mg/dL)\npH: 7.28 (7.35-7.45)\nPaCO2: 30 mmHg (35-45 mmHg)\nPaO2: 100 mmHg (80-100 mmHg)\nAnion Gap: 20 (Normal: 8-12)"
      },
      {
        "id": "exam",
        "title": "Physical Exam",
        "content": "General: Alert and oriented, but appears weak and dehydrated.\nSkin: Warm, dry, and flushed. Poor skin turgor.\nHEENT: Dry mucous membranes. Sunken eyes.\nRespiratory: Rapid and deep respirations (Kussmaul respirations). Acetone odor on breath.\nCardiovascular: Tachycardia, regular rhythm.\nAbdomen: Soft, non-tender.\nNeurological: Alert and oriented x3."
      },
      {
        "id": "orders",
        "title": "Care Plan",
        "content": "- Monitor blood glucose levels hourly.\n- Administer continuous insulin infusion per DKA protocol, titrating to blood glucose levels.\n- Administer 0.9% normal saline at 250 mL/hr.\n- Monitor potassium levels and administer potassium chloride 20 mEq IV every 4 hours as prescribed.\n- Obtain repeat lab values every 2 hours.\n- Strict I&O monitoring.\n- Educate patient on insulin administration, sick day management, and prevention of DKA."
      },
      {
        "id": "mar",
        "title": "MAR",
        "content": "- Insulin aspart (Novolog): 5 units subcutaneous before meals (07:00, 12:00, 18:00)\n- Insulin glargine (Lantus): 20 units subcutaneous at bedtime (22:00)\n- Insulin Regular (Humulin R): Continuous IV infusion at 2 units/hr, titrate per protocol.\n- Potassium Chloride (KCl): 20 mEq IV every 4 hours PRN for K+ <3.5 mEq/L"
      }
    ]
  },
  "rows": [
    {
      "id": "r1",
      "text": "Insulin Lispro (Humalog)"
    },
    {
      "id": "r2",
      "text": "Insulin Regular (Humulin R)"
    },
    {
      "id": "r3",
      "text": "Insulin NPH (Humulin N)"
    },
    {
      "id": "r4",
      "text": "Insulin Detemir (Levemir)"
    }
  ],
  "columns": [
    {
      "id": "c1",
      "text": "5-15 minutes"
    },
    {
      "id": "c2",
      "text": "30-60 minutes"
    },
    {
      "id": "c3",
      "text": "1-2 hours"
    },
    {
      "id": "c4",
      "text": "3-4 hours"
    }
  ],
  "correctAnswers": {
    "r1": [
      "c1"
    ],
    "r2": [
      "c2"
    ],
    "r3": [
      "c3"
    ],
    "r4": [
      "c3"
    ]
  },
  "pedagogy": {
    "bloomLevel": "analyze",
    "cjmmStep": "analyzeCues",
    "nclexCategory": "Pharmacological and Parenteral Therapies",
    "difficulty": 4,
    "topicTags": [
      "Insulin Management",
      "Diabetes Mellitus",
      "Pharmacology"
    ]
  },
  "rationale": {
    "correct": "Insulin lispro (Humalog) is a rapid-acting insulin analog with an onset of action within 5-15 minutes. Insulin Regular (Humulin R) is a short-acting insulin with an onset of action of 30-60 minutes. Insulin NPH (Humulin N) is an intermediate-acting insulin with an onset of action of 1-2 hours. Insulin Detemir (Levemir) is a long-acting insulin analog with an onset of action of 1-2 hours.",
    "incorrect": "Incorrect matching of the onset of action could lead to improper insulin administration, resulting in hyperglycemia or hypoglycemia. Each insulin type has a specific onset, peak, and duration of action, which must be considered for effective diabetes management.",
    "answerBreakdown": [
      {
        "id": "r1",
        "text": "Insulin Lispro (Humalog)",
        "rationale": "Insulin lispro is a rapid-acting insulin, indicated by the MAR, and is usually given just before a meal. Rapid-acting insulins have the fastest onset of action."
      },
      {
        "id": "r2",
        "text": "Insulin Regular (Humulin R)",
        "rationale": "Insulin Regular is a short-acting insulin, often given intravenously in DKA cases per the care plan. It has a faster onset than intermediate or long-acting insulins but is slower than rapid-acting ones."
      },
      {
        "id": "r3",
        "text": "Insulin NPH (Humulin N)",
        "rationale": "NPH insulin is an intermediate-acting insulin. This means it takes longer to be absorbed and reach the bloodstream compared to rapid and short-acting insulins."
      },
      {
        "id": "r4",
        "text": "Insulin Detemir (Levemir)",
        "rationale": "Insulin Detemir is a long-acting insulin analog. Long-acting insulins provide a basal level of insulin and have a slower onset compared to rapid and short-acting insulins, but similar to intermediate-acting insulins."
      }
    ],
    "clinicalPearls": [
      "When mixing insulins, always draw up the rapid-acting insulin first to avoid contaminating the vial with longer-acting insulin.",
      "The mnemonic 'RN' (Regular before NPH) helps remember the correct order for mixing insulins.",
      "Patients with DKA often require continuous insulin infusions to rapidly correct hyperglycemia and acidosis."
    ],
    "questionTrap": {
      "trap": "A common mistake is confusing the onset, peak, and duration of action for different insulin types. Students often mix up rapid and short-acting insulins.",
      "howToOvercome": "Use mnemonics and visual aids to differentiate between insulin types. Understanding the pharmacokinetic properties of each insulin is crucial."
    },
    "mnemonic": {
      "title": "Rapid Acting Insulin",
      "expansion": "Lispro (Humalog): '15 minutes feels like an HOUR during 2-3 rapid responses!'. Onset: 15 minutes, Peak: 1-2 hours, Duration: 2-3 hours."
    }
  },
  "scoring": {
    "method": "polytomous",
    "maxPoints": 4
  },
  "sentinelStatus": "healed_v2026_v9"
}